Keebeck Alpha »

Cambridge Ban shares owned by Keebeck Alpha

Quarter-by-quarter ownership of Cambridge Ban (CATC) shares owned by Keebeck Alpha from 13F filings

Historical chart of Keebeck Alpha investment in Cambridge Ban

Tip: Access up to 7 years of quarterly data

All positions including Cambridge Ban held by Keebeck Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cambridge Ban by Keebeck Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $270k 3.9k 69.40

More positions owned by Keebeck Alpha

American Equity Investment Life Holding (AEL)
stock
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Karuna Therapeutics Ord
Amedisys (AMED)
ImmunoGen
Hess (HES)
Sovos Brands
Pioneer Natural Resources (PXD)
Capstar Finl Hldgs (CSTR)
Neogames S A SHS (NGMS)
Capri Holdings SHS (CPRI)
Ishares Tr Russell 2000 Etf (IWM)
Consolidated Communications Holdings (CNSL)

View all positions for Keebeck Alpha

Top funds holding Cambridge Ban

Vanguard Group
Wellington Management Company
Cambridge Trust Company
Dimensional Fund Advisors
Endeavour Capital Advisors
Polaris Capital Management
Alliancebernstein
Hotchkis and Wiley Capital Management
Millennium Management
Arp Americas
Bank of New York Mellon
Royal Bank of Canada
Sentinel Pension Advisors
Brown Advisory Holdings Incorporated
Amica Mutual Insurance Company

View all funds holding Cambridge Ban